Studying clonal heterogeneity of acute myeloid leukemia under nutrient and chemotherapy stress. [PDF]
Mayerhofer C +13 more
europepmc +1 more source
Azacitidine as maintenance therapy in pediatric <i>de novo</i> acute myeloid leukemia. [PDF]
Wu C +5 more
europepmc +1 more source
Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold? [PDF]
Schreiber J, Hopfinger G, Gleixner KV.
europepmc +1 more source
Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes. [PDF]
Sallman DA +15 more
europepmc +1 more source
Effect of epigenetic modulation on metabolites from endophytes isolated from Embelia ribes. [PDF]
Terkar A +4 more
europepmc +1 more source
Case Report: The diagnostic and therapeutic crossroads: when myelofibrosis transforms into mixed phenotype acute leukemia. [PDF]
Liu Y, Zhang J, Du X, Liao L.
europepmc +1 more source
Ivosidenib for cholangiocarcinoma and acute myeloid leukaemia. [PDF]
europepmc +1 more source
5-Azacitidine Partially Resets the Subcellular Localization of YAP in Human Bone Marrow-Derived Mesenchymal Stem Cells. [PDF]
Takayama H, Kishi H, Kobashi G.
europepmc +1 more source
Hemi-Orolingual Angioedema in a Patient With VEXAS Syndrome. [PDF]
Suárez EU +2 more
europepmc +1 more source
Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review. [PDF]
Hoff FW, Trikha R, Groarke EM, Patel BA.
europepmc +1 more source

